Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. Van Mieghem NM, Unverdorben M, Hengstenberg C, Mollmann H, et al. N Engl J Med 2021 Aug 28. doi: 10.1056/NEJMoa2111016.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Van Mieghem NM, Unverdorben M, Hengstenberg C, Mollmann H, et al. Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. N Engl J Med 2021 Aug 28. doi: 10.1056/NEJMoa2111016.
PMID: 34449183